125 related articles for article (PubMed ID: 11536067)
1. [Treatment of community-acquired lung abscess associated with aspiration].
Ewig S; Schäfer H
Pneumologie; 2001 Sep; 55(9):431-7. PubMed ID: 11536067
[TBL] [Abstract][Full Text] [Related]
2. Severe community-acquired pneumonia in adults: current antimicrobial chemotherapy.
Niven DJ; Laupland KB
Expert Rev Anti Infect Ther; 2009 Feb; 7(1):69-81. PubMed ID: 19622058
[TBL] [Abstract][Full Text] [Related]
3. [Diagnosis and therapy of aspiration pneumonia].
Ott SR; Lode H
Dtsch Med Wochenschr; 2006 Mar; 131(12):624-8. PubMed ID: 16544240
[TBL] [Abstract][Full Text] [Related]
4. Ampicillin + sulbactam vs clindamycin +/- cephalosporin for the treatment of aspiration pneumonia and primary lung abscess.
Allewelt M; Schüler P; Bölcskei PL; Mauch H; Lode H;
Clin Microbiol Infect; 2004 Feb; 10(2):163-70. PubMed ID: 14759242
[TBL] [Abstract][Full Text] [Related]
5. Changing bacteriology of adult community-acquired lung abscess in Taiwan: Klebsiella pneumoniae versus anaerobes.
Wang JL; Chen KY; Fang CT; Hsueh PR; Yang PC; Chang SC
Clin Infect Dis; 2005 Apr; 40(7):915-22. PubMed ID: 15824979
[TBL] [Abstract][Full Text] [Related]
6. [Betalactam antibiotics combined with bectalactamases inhibitors. Amoxicillin-sulbactam].
Barcelona L; Marín M; Stamboulian D
Medicina (B Aires); 2008; 68(1):65-74. PubMed ID: 18416324
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of nonresolving and progressive pneumonia.
Menéndez R; Perpiñá M; Torres A
Semin Respir Infect; 2003 Jun; 18(2):103-11. PubMed ID: 12840791
[TBL] [Abstract][Full Text] [Related]
8. Empiric antimicrobial therapy for pediatric skin and soft-tissue infections in the era of methicillin-resistant Staphylococcus aureus.
Elliott DJ; Zaoutis TE; Troxel AB; Loh A; Keren R
Pediatrics; 2009 Jun; 123(6):e959-66. PubMed ID: 19470525
[TBL] [Abstract][Full Text] [Related]
9. Clinical relevance of antimicrobial resistance in the management of pneumococcal community-acquired pneumonia.
Feldman C
J Lab Clin Med; 2004 May; 143(5):269-83. PubMed ID: 15122171
[TBL] [Abstract][Full Text] [Related]
10. Macrolides are ideal for empiric therapy of community-acquired pneumonia in the immunocompetent host.
Vergis EN; Yu VL
Semin Respir Infect; 1997 Dec; 12(4):322-8. PubMed ID: 9436959
[TBL] [Abstract][Full Text] [Related]
11. [Diagnosis and therapy of abscess forming pneumonia].
Allewelt M; Lode H
Ther Umsch; 2001 Oct; 58(10):599-603. PubMed ID: 11695090
[TBL] [Abstract][Full Text] [Related]
12. [New quinolones for the treatment of community-acquired pneumonia--pro].
Zimmerli S
Dtsch Med Wochenschr; 2003 May; 128(19):1070. PubMed ID: 12736859
[No Abstract] [Full Text] [Related]
13. Community-acquired pneumonia.
Lynch JP; Martinez FJ
Curr Opin Pulm Med; 1998 May; 4(3):162-72. PubMed ID: 9675519
[TBL] [Abstract][Full Text] [Related]
14. [New quinolones for the treatment of community-acquired pneumonia--contra].
Egger M
Dtsch Med Wochenschr; 2003 May; 128(19):1071. PubMed ID: 12736860
[No Abstract] [Full Text] [Related]
15. In nosocomial pneumonia, optimizing antibiotics other than aminoglycosides is a more important determinant of successful clinical outcome, and a better means of avoiding resistance.
Schentag JJ; Birmingham MC; Paladino JA; Carr JR; Hyatt JM; Forrest A; Zimmer GS; Adelman MH; Cumbo TJ
Semin Respir Infect; 1997 Dec; 12(4):278-93. PubMed ID: 9436955
[TBL] [Abstract][Full Text] [Related]
16. Early and late treatment failure in community-acquired pneumonia.
Garcia-Vidal C; Carratalà J
Semin Respir Crit Care Med; 2009 Apr; 30(2):154-60. PubMed ID: 19296415
[TBL] [Abstract][Full Text] [Related]
17. [Empiric therapy of community-acquired pneumonia: a transatlantic controversy].
Garin N; Nendaz M
Rev Med Suisse; 2006 Jan; 2(50):289-90, 292-4. PubMed ID: 16503046
[TBL] [Abstract][Full Text] [Related]
18. A cost-effectiveness analysis of antimicrobial treatment of community-acquired pneumonia taking into account resistance in Belgium.
Martin M; Moore L; Quilici S; Decramer M; Simoens S
Curr Med Res Opin; 2008 Mar; 24(3):737-51. PubMed ID: 18230196
[TBL] [Abstract][Full Text] [Related]
19. Hospital-acquired respiratory tract infections: clinical experience with beta-lactam/beta-lactamase inhibitors.
Akova M
Int J Clin Pract Suppl; 2002 Mar; (125):19-27; discussion 37-9. PubMed ID: 12014853
[TBL] [Abstract][Full Text] [Related]
20. Evolution of amoxicillin/clavulanate in the treatment of adults with acute bacterial rhinosinusitis and community-acquired pneumonia in response to antimicrobial-resistance patterns.
File TM; Benninger MS; Jacobs MR
Clin Lab Med; 2004 Jun; 24(2):531-51. PubMed ID: 15177852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
